Yes, insurance did cover the higher price brand drug during that shortage period
Interesting - wonder if that's why V scrips spiked so high last week while GV dropped again - Hikma launched w/o sufficient supply and they're running out of it already, so scrips are getting filled with V, and insurers are having to cover it - at least I hope that's what's going on.
Market Data 
Markets 
AI
